WARRANT TO PURCHASE SHARES OF COMMON STOCK OF PROTALIX BIOTHERAPEUTICS, INC.Warrant Agreement • March 12th, 2020 • Protalix BioTherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Warrant is issued to __________________ (including any successors or assigns, the “Warrantholder”), which is hereby acknowledged in connection with that certain Securities Purchase Agreement, dated as of March [●], 2020 by and between Protalix BioTherapeutics, Inc., a Delaware corporation (the “Company”) (the “Purchase Agreement”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 12th, 2020 • Protalix BioTherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March [--], 2020, between Protalix BioTherapeutics, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), and the purchaser identified on the signature page attached hereto (the “Purchaser”).
